Jaris Computational Biology Centre has set a new standard in computational biology, by reshaping the scientific research ...

Schrödinger partners with Novartis for advanced computational drug discovery. Q3 revenue rose 10% in software, though total ...

Google DeepMind releases AlphaFold 3's source code to academics, marking a significant advance in AI-powered molecular biology and drug discovery, while balancing open science with commercial ...

The global artificial intelligence (AI) in drug discovery market is projected to reach USD 6.89 billion by 2029 from USD 1.86 ...

The code underlying the Nobel-prize-winning tool for modelling protein structures can now be downloaded by academics.

The companies also have an expanded three-year software agreement that will increase access for Novartis to Schrödinger’s ...

Schrödinger today announced a multi-target collaboration and expanded software licensing agreement with Novartis.

Tech giants are set to bid on a NIS 240 million tender to build supercomputing infrastructure for Israeli tech startups and ...

The process of identifying promising small molecule drug candidates that target cancer checkpoints ... The researchers used a ...

Chemistry and life science teams can instantly impact drug discovery and upskill work through Balto’s data collection and modeling toolkitSAN FRANCISCO, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Deep Origin, ...

Schrodinger (SDGR) today announced a research collaboration and license agreement with Novartis (NVS) to advance multiple development ...

Patient-derived organoids (PDOs) are revolutionizing cancer research, enhancing drug testing and personalized treatment ...